A.forall announced through its U.S. subsidiary, Milla Pharmaceuticals Inc., that it has received Abbreviated New Drug Application (ANDA) approval by the U.S. Food and Drug Administration (FDA) for 8.4 ...
WEST COLUMBIA, S.C., May 31, 2017 /PRNewswire/ -- Nephron Pharmaceuticals Corporation (Nephron) will address the recently announced critical drug shortage of 8.4% Sodium Bicarbonate Injection, USP on ...
CHARLOTTE, N.C.--(BUSINESS WIRE)-- Premier Inc. (NASDAQ: PINC), through its ProvideGxâ„¢ program, has partnered with Exela Pharma Sciences, LLC, to supply sodium bicarbonate injection to healthcare ...
December 29, 2010 — A voluntary recall has been issued for 39 lots of American Regent's sodium bicarbonate injection because of the presence of particulate matter, the US Food and Drug Administration ...
Exela Pharma Sciences is recalling an additional 14 lots of Sodium Bicarbonate Injection, USP, 8.4%, 50mEq/50 mL vial, 20-count carton. In total, the Company is recalling 63 lots of the product due to ...
Lacerations aren’t typically the sort of side effect one associates with a faulty drug, but in Exela Pharma Sciences’ case, the threat has prompted a mass recall of an injectable used to treat a ...
SterRx, LLC today announced the voluntary nationwide recall of three lots of Sodium Bicarbonate in 5% Dextrose Injection 150mEq per 1,000 mL due to waterborne microbial contamination. SterRx, LLC has ...
Hospira, Inc., a Pfizer company, is voluntarily recalling the lots listed in the table below of 4.2% Sodium Bicarbonate Injection, USP ABBOJECT® Glass Syringe, 5 mEq/10 mL; 8.4% Sodium Bicarbonate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results